Skip to main content
. Author manuscript; available in PMC: 2024 Jun 6.
Published in final edited form as: Circulation. 2023 Apr 12;147(23):1748–1757. doi: 10.1161/CIRCULATIONAHA.122.062752

Table 1. Baseline Demographics by CrCl category.

CrCl calculated at baseline, using the Cockcroft-Gault formula. Frequencies are shown as n (percentage), and continuous variables as mean (SD), with the exception of CHA2DS2-VASc, which is shown as median (IQR). AF: atrial fibrillation; BMI: body mass index; CrCl: creatinine clearance; GIB: gastrointestinal bleed; HTN: hypertension; VKA: vitamin K antagonist

CrCl Category <30 30-44 45-59 60-89 ≥90 Overall
n 510 8409 15477 28891 18277 71683
 
Female 335 (65.7%) 4721 (56.1%) 7118 (46.0%) 10068 (34.8%) 4425 (24.2%) 26715 (37.3%)
Age 80.2 (6.8) 78.5 (6.6) 75.3 (6.8) 70.6 (7.7) 62.6 (8.7) 70.6 (9.4)
CrCl 26.6 (3.0) 38.7 (4.1) 52.7 (4.3) 73.5 (8.5) 116.1 (26.7) 75.5 (30.5)
BMI 23.6 (4.4) 25.2 (4.4) 26.7 (4.4) 28.9 (4.7) 33.6 (6.4) 29.2 (5.9)
Weight 59.9 (13.3) 66.3 (13.3) 72.9 (13.6) 82.5 (14.7) 101.5 (20.3) 83.2 (20.0)
Smoking 190 (37.3%) 2984 (35.5%) 6104 (39.4%) 12659 (43.8%) 9283 (50.8%) 31265 (43.6%)
Diabetes 129 (25.3%) 2118 (25.2%) 4212 (27.2%) 8607 (29.8%) 6996 (38.3%) 22087 (30.8%)
Stroke 129 (25.3%) 2517 (29.9%) 4737 (30.6%) 8376 (29.0%) 4361 (23.9%) 20147 (28.1%)
Prior VKA Use 310 (60.8%) 5433 (64.6%) 10328 (66.7%) 19698 (68.2%) 13056 (71.4%) 48892 (68.2%)
Antiplatelet Use 196 (38.4%) 3168 (37.7%) 5711 (36.9%) 10142 (35.1%) 6213 (34.0%) 25464 (35.5%)
CHA2DS2-VASc 4.9 (1.4) 4.8 (1.4) 4.5 (1.4) 3.9 (1.5) 3.2 (1.4) 4.0 (1.5)
AF type
  Paroxysmal 89 (17.5%) 1880 (22.4%) 3574 (23.1%) 6870 (23.8%) 4174 (22.8%) 16609 (23.2%)
  Persistent/Permanent 421 (82.5%) 6526 (77.6%) 11903 (76.9%) 22015 (76.2%) 14098 (77.1%) 55059 (76.8%)
Coronary Disease 201 (39.4%) 2753 (32.7%) 5037 (32.5%) 9137 (31.6%) 5513 (30.2%) 22674 (31.6%)
HTN 444 (87.1%) 7285 (86.6%) 13465 (87.0%) 25191 (87.2%) 16380 (89.6%) 62863 (87.7%)
Heart Failure 271 (53.1%) 4107 (48.8%) 6884 (44.5%) 12750 (44.1%) 9231 (50.5%) 33276 (46.4%)
Prior GIB 23 (4.5%) 320 (3.8%) 506 (3.3%) 750 (2.6%) 429 (2.3%) 2030 (2.8%)
Prior Non-GIB 55 (10.8%) 500 (5.9%) 861 (5.6%) 1517 (5.3%) 1049 (5.7%) 3989 (5.6%)